We are live on ! Find out more
TA

TLS Advisors Portfolio holdings

AUM $34M
1-Year Est. Return 11.11%
This Fund
S&P 500
This Quarter Est. Return
+16.76%
1 Year Est. Return
+11.11%
3 Year Est. Return
+36.15%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$19.4M
AUM Growth
-$845K
Cap. Flow
-$4.49M
Cap. Flow %
-23.08%
Top 10 Hldgs %
96.33%
Holding
21
New
–
Increased
–
Reduced
6
Closed
7

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
SI
Silvergate Capital Corporation
SI
+$1.39M
2
TSLA icon
Tesla
TSLA
+$739K
3
META icon
Meta Platforms (Facebook)
META
+$681K
4
FSTX
F-star Therapeutics, Inc. Common Stock
FSTX
+$343K
5
LITS
Lite Strategy Inc
LITS
+$264K

Sector Composition

Rank Sector Weight
1 Healthcare 51.09%
2 Energy 32.89%
3 Communication Services 13.27%
4 Miscellaneous 1.39%
5 Consumer Discretionary 1.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EQT icon
1
EQT Corp
EQT
$34.3B
$4.81M 24.75%
150,800
– –
OVID icon
2
Ovid Therapeutics
OVID
$572M
$3.52M 18.08%
1,380,346
-110,188
-7% -$261K
XOMA
3
DELISTED
Xoma
XOMA
$2.54M 13.08%
120,465
-3,559
-3% -$74.8K
META icon
4
Meta Platforms (Facebook)
META
$1.45T
$2.24M 11.54%
10,589
-4,000
-27% -$681K
RRC icon
5
Range Resources
RRC
$9.73B
$1.58M 8.15%
59,823
– –
OABI icon
6
OmniAb
OABI
$670M
$1.31M 6.75%
356,592
-30,000
-8% -$113K
XENE icon
7
Xenon Pharmaceuticals
XENE
$6B
$1.21M 6.21%
33,756
– –
BLU
8
DELISTED
BELLUS Health Inc.
BLU
$905K 4.65%
125,731
– –
NBIS
9
Nebius Group N.V.
NBIS
$59.4B
$337K 1.73%
17,811
– –
EWS icon
10
iShares MSCI Singapore ETF
EWS
$1.23B
$270K 1.39%
13,600
– –
HOV icon
11
Hovnanian Enterprises
HOV
$743M
$263K 1.35%
3,872
-2,600
-40% -$159K
LITS
12
Lite Strategy Inc
LITS
$34M
$244K 1.25%
53,250
-47,264
-47% -$264K
REGN icon
13
Regeneron Pharmaceuticals
REGN
$83.2B
$205K 1.05%
250
– –
NIRWW
14
DELISTED
Near Intelligence, Inc. Warrant
NIRWW
$1K 0.01%
10,000
– –
AFMD
15
DELISTED
Affimed
AFMD
– –
-16,197
Closed -$201K
NKTX icon
16
Nkarta
NKTX
$197M
– –
-26,842
Closed -$161K
NNDM
17
Nano Dimension
NNDM
$333M
– –
-22,000
Closed -$51K
TSLA icon
18
Tesla
TSLA
$1.4T
– –
-6,000
Closed -$739K
APTO
19
DELISTED
Aptose Biosciences, Inc.
APTO
– –
-199
Closed -$52K
SI
20
DELISTED
Silvergate Capital Corporation
SI
– –
-79,795
Closed -$1.39M
FSTX
21
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
– –
-54,298
Closed -$343K

Similar funds

QC
Quantessence Capital New York $34M AUM 100.19% 1-Year Est. Return
CPCM
Cornerstone Partners Capital Management Charlottesville, Virginia $34.4M AUM 26.36% 1-Year Est. Return
EGI
EAM Global Investors Solana Beach, California $34.8M AUM 275.91% 1-Year Est. Return
SL
Savior LLC Wellesley Hills, Massachusetts $34.9M AUM 32.88% 1-Year Est. Return
LWM
Laidlaw Wealth Management New York City, New York $35.1M AUM 38.91% 1-Year Est. Return
RF
Roberts Foundation San Mateo, California $35.1M AUM 4.07% 1-Year Est. Return
MUMSS
Mitsubishi UFJ Morgan Stanley Securities Tokyo, Japan $32.7M AUM
CGIM
Cannon Global Investment Management Davie, Florida $35.4M AUM 47.4% 1-Year Est. Return

TLS Advisors's Q1 2023 Portfolio in Review

As of Q1 2023, TLS Advisors held 21 positions worth $19.4M, down 4.2% from $20.3M the previous quarter. Its ten largest holdings account for 96% of the portfolio.

TLS Advisors withdrew a net $4.49M in Q1 2023, closing 7 positions and reducing 6 holdings. Its most notable exit was Silvergate Capital Corporation, an estimated $1.39M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 51% of assets, up from 50% a quarter earlier, followed by Energy and Communication Services.

  • TLS Advisors's biggest Q1 2023 reduction was Meta Platforms (Facebook), cutting an estimated $681K.
  • TLS Advisors fully exited Silvergate Capital Corporation in Q1 2023, selling an estimated $1.39M.
  • TLS Advisors's ten largest holdings make up 96% of its $19.4M portfolio in Q1 2023.
  • TLS Advisors opened 0 new positions and closed 7 in Q1 2023.
  • TLS Advisors's portfolio value fell 4.2% quarter-over-quarter to $19.4M.

Based on TLS Advisors's 13F filing for Q1 2023, filed 16 Nov 2023.